##  [Novartis Announces FDA Approval of Xolair® (omalizumab) for Chronic Idiopathic Urticaria (CIU), a Form of Chronic Hives](/us-en/news/media-releases/novartis-announces-fda-approval-xolair-omalizumab-chronic-idiopathic-urticaria-ciu-form-chronic-hives-0 "Novartis Announces FDA Approval of Xolair® (omalizumab) for Chronic Idiopathic Urticaria (CIU), a Form of Chronic Hives") 

  Mar 21, 2014